BCG-induced non-specific effects on heterologous infectious disease in Ugandan neonates: an investigator-blind randomised controlled trial

BACKGROUND: Trials done in infants with low birthweight in west Africa suggest that BCG vaccination reduces all-cause mortality in the neonatal period, probably because of heterologous protection against non-tuberculous infections. This study investigated whether BCG alters all-cause infectious dise...

Descripción completa

Detalles Bibliográficos
Autores principales: Prentice, Sarah, Nassanga, Beatrice, Webb, Emily L, Akello, Florence, Kiwudhu, Fred, Akurut, Hellen, Elliott, Alison M, Arts, Rob J W, Netea, Mihai G, Dockrell, Hazel M, Cose, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science ;, The Lancet Pub. Group 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222005/
https://www.ncbi.nlm.nih.gov/pubmed/33609457
http://dx.doi.org/10.1016/S1473-3099(20)30653-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222005/
https://www.ncbi.nlm.nih.gov/pubmed/33609457
http://dx.doi.org/10.1016/S1473-3099(20)30653-8

Ejemplares similares